Home › Funds › ORBIMED ADVISORS LLC › GPCR

ORBIMED ADVISORS LLC position in GPCR

STRUCTURE THERAPEUTICS INC · Health Care

ORBIMED ADVISORS LLC reported holding 2,209,400 shares of GPCR (STRUCTURE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$118.6M, representing 2.38% of its reported portfolio and ranking #7 among its reported holdings. ORBIMED ADVISORS LLC has disclosed GPCR holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)2.21M sh
Reported value held$118.58M
Portfolio Weight2.38%
First reportedQ2 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ORBIMED ADVISORS LLC's GPCR position evolved

ORBIMED ADVISORS LLC first disclosed a stake in GPCR in Q2 2024 at 125,000 shares (US$4.9M). The position peaked in Q2 2026 at 2,209,400 shares, worth US$118.6M. Across 9 filings, ORBIMED ADVISORS LLC increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 2,209,400 shares valued at US$118.6M — an increase of 733,997 shares quarter over quarter.. Notable position changes include a 207% increase in Q3 2024 (shares fell 38% over the following quarter), a 61% trim in Q4 2024 (shares fell 36% over the following quarter), a 700% increase in Q2 2025 (shares rose 35% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 125.00K $4.91M New
Q3 2024 383.70K $16.84M Add
Q4 2024 150.00K $4.07M Reduce
Q1 2025 150.00K $2.60M Hold
Q2 2025 1.20M $24.87M Add
Q3 2025 1.14M $31.90M Reduce
Q4 2025 1.16M $80.80M Add
Q1 2026 1.48M $71.11M Add
Q2 2026 2.21M $118.58M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GPCR and 13F data

GPCR (STRUCTURE THERAPEUTICS INC) is a Health Care company. 32 other funds we track also report a position in GPCR — the largest reported positions include Avoro Capital Advisors LLC (US$351.8M), Deep Track Capital, LP (US$254.4M), BVF INC/IL (US$180.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GPCR

All GPCR fund holders →

FAQ

How long has ORBIMED ADVISORS LLC held GPCR?

ORBIMED ADVISORS LLC has disclosed GPCR holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

What is ORBIMED ADVISORS LLC's current position in GPCR?

As of Q2 2026, ORBIMED ADVISORS LLC holds 2.21M shares of GPCR (STRUCTURE THERAPEUTICS INC), valued at $118.58M, representing 2.38% of its reported portfolio and ranking #7.

Has ORBIMED ADVISORS LLC been buying or selling GPCR?

In the latest 13F filing (Q2 2026), ORBIMED ADVISORS LLC increased its position in GPCR. The position peaked in Q2 2026 at 2.21M shares.

Which other funds hold GPCR?

Other major institutional holders of GPCR include Avoro Capital Advisors LLC, Deep Track Capital, LP, BVF INC/IL, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.